Instead of racing against each other, the companies are banding together to fight diabetes, arthritis and Alzheimer's.
Information about your prescriptions is routinely bought and resold. IMS Health, one of the most active traders in the field, wants to go public.
The pharmaceutical company's future isn't nearly as dark as the bears would want you to think.
These miserable issues have left investors sleepless all year. Is the worst over after this annus horribilis?
The number of diabetics worldwide is expected to hit 550 million in less than 20 years. The undisputed market leader is the best way to cash in on this troubling trend.
Companies in diabetes treatment, weight management and weight-loss drugs could see see huge growth.
The company pays one of the best dividends in the sector at an annual yield of 4 percent.
There are plenty of quarterly reports on deck. Here's what to expect from some of the biggest names.
VIDEO ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
Serious issues like drought and the deterioration of the developed world spell opportunity for this industry leader.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
There are plenty of people who are willing to buy your silver and other valuables, but most won't give you top dollar for what you have.
MUST-SEE ON MSN
A charcuterie master shares his process for cold-smoking meat at home.
- Jetpacks about to go mainstream
- Weird things covered by home insurance
- Bing: 70 percent of adults report 'digital eye strain'